Micropharma Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Micropharma Limited - overview
Established
2004
Location
Montreal, QC, Canada
Primary Industry
Biotechnology
About
Founded in 2004 and based in Quebec, Canada, Micropharma Limited is a biotechnology research company specializing in the discovery and development of bacteria-based biotherapeutics for metabolic diseases. The company employs a proprietary discovery and development platform, ProSelect, which aids in identifying and producing bacteria capable of expressing phenotypic features that target metabolic pathways with therapeutic potential. ProSelect screens and chooses bacteria, while Micropharma uses modern fermentation and optimization procedures to increase the expression of these traits. The company developed Cardioviva™, a disease-specific, biomarker-linked therapeutic bacteria product, that can show the efficacy of ProSelect.
Cardioviva™ is a bile-salt-hydrolase (BSH)-active bacteria that helps in decreasing LDL-C (low-density lipoprotein cholesterol) in two placebo-controlled, randomized, multicenter trials.
Current Investors
Seventure Partners
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.micropharma.net/
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Micropharma Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.